Glaxosmithkline Share News (GSK)

Novartis to investigate bribery claims at Alcon unit in China

ZURICH/BEIJING, Sept 17 (Reuters) - Novartis said on Tuesday it would investigate allegations published in a Chinese newspaper that its eye care unit Alcon bribed doctors. The 21st Century Business Herald, citing a whistleblower called "Zorro", said that Alcon offered money to doctors in mo

China reminds hospitals not to push baby milk

BEIJING, Sept 17 (Reuters) - China's Health Ministry reminded hospitals on Tuesday that they are not allowed to push the sale of baby milk to new mothers after Chinese state television said Danone had bribed hospital staff to give its milk powder to new-born babies. China Central Television

Tuesday broker round-up UPDATE

Aggreko: Credit Suisse reduces target price from 2000p to 1400p and downgrades from neutral to underperform. Antofagasta: WH Ireland downgrades to neutral. Associated British Food: Nomura moves target price from 1650p to 1670p staying with its reduce rating. Aviva: Berenberg downgrades from hold

UK lawmakers urge more clinical trial transparency

LONDON, Sept 17 (Reuters) - The failure by drugmakers and researchers to publish results from all clinical trials - whether good or bad - is risking patient safety, British lawmakers said on Tuesday in a report that adds to pressure for more transparency. The parliamentary Science and Techn

Director Dealings - GlaxoSmithKline Manager Awarded Shares

MARKET PULSE- Tesco, Regeneron, GSK, Cooper Tire

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) Sept 16 (Reuters) - Some U.S. stocks to watch on Monday: FUTURES HIGHER AS SUMMERS WIT

MARKET PULSE- Tesco, Regeneron, GSK, Boeing, Boise

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) Sept 16 (Reuters) - Some U.S. stocks to watch on Monday: FUTURES HIGHER AS SUMMERS WIT

MARKET PULSE- Tesco, Regeneron, GSK, Boeing

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s) Sept 16 (Reuters) - Some U.S. stocks to watch on Monday: ** PLURISTEM THERAPEUTICS INC, Friday close $3.22, up 8.7 pct premarket The Israel-based compa

UPDATE: GSK Drug Combination Granted Priority Review By US Regulators

GSK Drug Combination Granted Priority Review Status By US Regulators

UPDATE 1-GSK cancer drug combination wins US priority review

LONDON, Sept 16 (Reuters) - A combination treatment from GlaxoSmithkline for melanoma, the deadliest form of skin cancer, has won priority review from U.S. regulators. The move means the Food and Drug Administration will now decide whether to approve the dual use of Tafinlar, also known as

GSK cancer drug combination gets U.S. priority review

LONDON, Sept 16 (Reuters) - A combination treatment from GlaxoSmithkline for melanoma, the deadliest form of skin cancer, has won priority review from U.S. regulators. GSK said on Monday the Food and Drug Administration had prioritised a review of a combination of dabrafenib and trametinib

Genmab shares jump as FDA grants drug accelerated status

COPENHAGEN, Sept 16 (Reuters) - Shares in Danish biotech firm Genmab jumped 8.5 percent at open on Monday after the company said late on Friday the United States Food and Drug Administration (FDA) had granted its leukaemia drug "Breakthrough Therapy Designation". Breakthrough Therapy Desig

Friday broker round-up UPDATE

ASOS: Panmure Gordon raises target price from 4555p to 5950p maintaining a buy recommendation. AstraZeneca: Jefferies reduces target price from 3200p to 2850p and retains a hold recommendation. Barclays: Jefferies initiates with a target price of 367p and a buy recommendation. Barratt Development

UPDATE 1-Chinese authorities probing German drugmaker Bayer

SHANGHAI, Sept 13 (Reuters) - Chinese authorities visited a local office of German drugmaker Bayer AG in late August to investigate a potential case of unfair competition, the company said on Friday. China's regulators have been probing numerous international and Chinese drugs firms, with i